查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1593929

瘧疾疫苗市場：按類型、藥物和最終用戶分類 - 全球預測 2025-2030

Malaria Vaccine Market by Type (Erythrocytic Vaccine, Multi-Antigen Vaccine, Pre-Erythrocytic Vaccine), Agent (Anopheles Species, Plasmodium Falciparum, Plasmodium Vivax), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年瘧疾疫苗市場規模預估為6,434萬美元，預計2024年將達8,088萬美元，複合年成長率為25.78%，預計2030年將達3,2066萬美元。

瘧疾疫苗市場的定義是其在瘧疾控制中的關鍵作用，特別是在瘧疾流行地區，主要是非洲、東南亞和拉丁美洲部分地區。瘧疾導致顯著的發病率和死亡率，並繼續構成全球健康負擔，這一事實凸顯了對瘧疾疫苗的需求。瘧疾疫苗的主要用途是進行免疫，以降低感染率和傳播，有助於改善受影響地區的公共衛生並提高經濟生產力。主要最終用戶包括政府衛生機構、非政府組織、公共衛生計劃和一定規模的私人醫療保健提供者。根據市場洞察，增加研發投資、生物技術進步以及全球健康夥伴關係關係等因素正在對市場成長產生正面影響。最近的進展包括世界衛生組織核准RTS,S/AS01 (Mosquirix) 疫苗，為擴大到大規模免疫規劃提供了重大機會。為了有效利用這些機會，建議與國際衛生組織建立策略夥伴關係並投資低溫運輸基礎設施。

主要市場統計
基準年[2023] 6434萬美元
預測年份 [2024] 8088萬美元
預測年份 [2030] 32066萬美元
複合年成長率（%） 25.78%

限制和挑戰包括疫苗分發的後勤障礙、偏遠地區缺乏意識、潛在的副作用和疫苗儲存問題，特別是在資源有限的環境中。此外，資金籌措的不確定性和對疫苗部分抗藥性的瘧疾菌株的出現對進一步成長構成了障礙。然而，創新機會比比皆是，特別是在開發具有更廣泛毒株覆蓋範圍和更高功效的疫苗方面。探索具有成本效益的製造方法和多平台技術，使交付更容易，將推動業務成長。該市場在嚴格的監管框架的陰影下發展，仍然高度活躍，很大程度上是由對永續性和可及性的需求所驅動的。因此，企業必須優先考慮技術主導的解決方案，以提高低收入地區的物流和配送效率，並專注於確保可負擔性的合作模式。

市場動態：揭示快速發展的瘧疾疫苗市場的關鍵市場洞察

供需的動態交互作用正在改變瘧疾疫苗市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 常規免疫項目快速增加
    • 提高瘧疾疫苗的可用性、可近性和政府的有利支持
    • 提高患者對瘧疾的認知和發病率
  • 市場限制因素
    • 疫苗高成本
  • 市場機會
    • 新型佐劑和突破性疫苗輸送計劃的不斷出現
    • 製藥業在疫苗方面不斷取得進展
  • 市場挑戰
    • 嚴格監管場景

波特五力：駕馭瘧疾疫苗市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解瘧疾疫苗市場的外部影響

外部宏觀環境因素在塑造瘧疾疫苗市場表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解瘧疾疫苗市場的競爭格局

瘧疾疫苗市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們的公司能夠應對日益激烈的競爭。

FPNV 定位矩陣瘧疾疫苗市場供應商的績效評估

FPNV 定位矩陣是評估瘧疾疫苗市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製瘧疾疫苗市場的成功之路

瘧疾疫苗市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加常規免疫計劃
      • 改善瘧疾疫苗的供應、可近性和政府的有利支持
      • 提高患者對瘧疾的認知和發病率
    • 抑制因素
      • 疫苗高成本
    • 機會
      • 新佐劑和創新疫苗管理方案的不斷出現
      • 製藥業在疫苗方面取得進展
    • 任務
      • 嚴格監管場景
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章瘧疾疫苗市場：依類型

  • 紅血球疫苗
  • 多重抗原疫苗
  • 前紅血球疫苗

第7章 瘧疾疫苗市場（依代理商）

  • 依蚊
  • 瘧疾原蟲
  • 瘧疾原蟲

第8章瘧疾疫苗市場：依最終用戶分類

  • 診所
  • 社區中心
  • 醫院

第9章美洲瘧疾疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區瘧疾疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲瘧疾疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Amyris, Inc.
  • Bharat Biotech International Limited
  • Cadila Healthcare Ltd.
  • CellFree Sciences Co.,Ltd.
  • GenVec, Inc.
  • GlaxoSmithKline PLC
  • Ipca Laboratories Limited
  • Merck & Co., Inc
  • Mymetics Corporation
  • Novartis AG
  • Novavax, Inc.
  • Precigen, Inc.
  • Sanaria Inc.
  • Sumaya Biotech
  • Sun Pharmaceutical Industries Limited
Product Code: MRR-035DA3C63710

The Malaria Vaccine Market was valued at USD 64.34 million in 2023, expected to reach USD 80.88 million in 2024, and is projected to grow at a CAGR of 25.78%, to USD 320.66 million by 2030.

The malaria vaccine market is defined by its critical role in combating the malaria epidemic, particularly in malaria-endemic regions predominantly across Africa, Southeast Asia, and parts of Latin America. The necessity of a malaria vaccine is underscored by the persistent global health burden malaria poses, leading to significant morbidity and mortality. The primary application of malaria vaccines involves preventive inoculations to reduce infection rates and transmission, thus contributing to public health improvement and economic productivity in affected regions. Key end-users include government health bodies, non-governmental organizations, public health initiatives, and potentially private healthcare providers as distribution scales. Market insights indicate that factors such as increasing R&D investments, advancements in biotechnology, and global health partnerships are positively influencing market growth. Recent developments include WHO's approval of the RTS,S/AS01 (Mosquirix) vaccine, which presents significant opportunity for expansion into larger immunization programs. Leveraging strategic partnerships with international health agencies and investing in cold chain infrastructure are recommended to harness these opportunities effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 64.34 million
Estimated Year [2024] USD 80.88 million
Forecast Year [2030] USD 320.66 million
CAGR (%) 25.78%

Limitations and challenges include logistical hurdles in vaccine distribution, lack of awareness in remote areas, potential side effects, and vaccine storage issues, particularly in resource-limited settings. Moreover, funding uncertainties and the emergence of malaria strains with partial vaccine resistance pose additional growth barriers. However, opportunities for innovation abound, particularly in developing vaccines with broader strain coverage and improved efficacy. Research into cost-effective production methods and multi-platform technologies that facilitate easier delivery can drive business growth. The market, evolving under the shadow of stringent regulatory frameworks, remains highly dynamic and primarily driven by the need for sustainability and accessibility. Hence, companies must focus on collaborative models that ensure affordability and prioritize technology-driven solutions that enhance logistics and distribution efficiency in lower-income regions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Malaria Vaccine Market

The Malaria Vaccine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Proliferation in the number of routine immunizations programs
    • Rising availability, accessibility and favorable government support for malaria vaccine
    • Growing patient awareness and incidence of malaria
  • Market Restraints
    • High cost of the vaccines
  • Market Opportunities
    • Ongoing advent of novel adjuvants and breakthrough vaccine delivery programs
    • Rising advancements in pharmaceutical industry for vaccines
  • Market Challenges
    • Rigid regulative scenarios

Porter's Five Forces: A Strategic Tool for Navigating the Malaria Vaccine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Malaria Vaccine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Malaria Vaccine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Malaria Vaccine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Malaria Vaccine Market

A detailed market share analysis in the Malaria Vaccine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Malaria Vaccine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Malaria Vaccine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Malaria Vaccine Market

A strategic analysis of the Malaria Vaccine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Malaria Vaccine Market, highlighting leading vendors and their innovative profiles. These include Amyris, Inc., Bharat Biotech International Limited, Cadila Healthcare Ltd., CellFree Sciences Co.,Ltd., GenVec, Inc., GlaxoSmithKline PLC, Ipca Laboratories Limited, Merck & Co., Inc, Mymetics Corporation, Novartis AG, Novavax, Inc., Precigen, Inc., Sanaria Inc., Sumaya Biotech, and Sun Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Malaria Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Erythrocytic Vaccine, Multi-Antigen Vaccine, and Pre-Erythrocytic Vaccine.
  • Based on Agent, market is studied across Anopheles Species, Plasmodium Falciparum, and Plasmodium Vivax.
  • Based on End-User, market is studied across Clinics, Community Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Proliferation in the number of routine immunizations programs
      • 5.1.1.2. Rising availability, accessibility and favorable government support for malaria vaccine
      • 5.1.1.3. Growing patient awareness and incidence of malaria
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advent of novel adjuvants and breakthrough vaccine delivery programs
      • 5.1.3.2. Rising advancements in pharmaceutical industry for vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Rigid regulative scenarios
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Malaria Vaccine Market, by Type

  • 6.1. Introduction
  • 6.2. Erythrocytic Vaccine
  • 6.3. Multi-Antigen Vaccine
  • 6.4. Pre-Erythrocytic Vaccine

7. Malaria Vaccine Market, by Agent

  • 7.1. Introduction
  • 7.2. Anopheles Species
  • 7.3. Plasmodium Falciparum
  • 7.4. Plasmodium Vivax

8. Malaria Vaccine Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Community Centers
  • 8.4. Hospitals

9. Americas Malaria Vaccine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Malaria Vaccine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Malaria Vaccine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amyris, Inc.
  • 2. Bharat Biotech International Limited
  • 3. Cadila Healthcare Ltd.
  • 4. CellFree Sciences Co.,Ltd.
  • 5. GenVec, Inc.
  • 6. GlaxoSmithKline PLC
  • 7. Ipca Laboratories Limited
  • 8. Merck & Co., Inc
  • 9. Mymetics Corporation
  • 10. Novartis AG
  • 11. Novavax, Inc.
  • 12. Precigen, Inc.
  • 13. Sanaria Inc.
  • 14. Sumaya Biotech
  • 15. Sun Pharmaceutical Industries Limited

LIST OF FIGURES

  • FIGURE 1. MALARIA VACCINE MARKET RESEARCH PROCESS
  • FIGURE 2. MALARIA VACCINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MALARIA VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MALARIA VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MALARIA VACCINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MALARIA VACCINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MALARIA VACCINE MARKET SIZE, BY AGENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MALARIA VACCINE MARKET SIZE, BY AGENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MALARIA VACCINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MALARIA VACCINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MALARIA VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MALARIA VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MALARIA VACCINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MALARIA VACCINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MALARIA VACCINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MALARIA VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MALARIA VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MALARIA VACCINE MARKET DYNAMICS
  • TABLE 7. GLOBAL MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MALARIA VACCINE MARKET SIZE, BY ERYTHROCYTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MALARIA VACCINE MARKET SIZE, BY MULTI-ANTIGEN VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MALARIA VACCINE MARKET SIZE, BY PRE-ERYTHROCYTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MALARIA VACCINE MARKET SIZE, BY ANOPHELES SPECIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MALARIA VACCINE MARKET SIZE, BY PLASMODIUM FALCIPARUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MALARIA VACCINE MARKET SIZE, BY PLASMODIUM VIVAX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MALARIA VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MALARIA VACCINE MARKET SIZE, BY COMMUNITY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MALARIA VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES MALARIA VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. MALARIA VACCINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. MALARIA VACCINE MARKET, FPNV POSITIONING MATRIX, 2023